CRA looking into pharmaceutical giant Eli Lilly Canada’s taxes
OTTAWA — CRA found some revenues for the U.S. pharmaceutical giant behind diabetes and weight-loss medication Mounjaro lower than expected and suspects the company didn't pay enough taxes in 2020, National Post has learned.
Read More
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on nationalpost.com — the content belongs to National Post.